Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Retin Cases Brief Rep ; 15(6): 767-771, 2021 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-31299027

RESUMO

PURPOSE: To report optical coherence tomography angiography findings obtained in two patients with solar retinopathy. METHODS: Two case reports. RESULTS: Two patients presented with blurry vision after sun gazing during the recent solar eclipse and were found to have characteristic foveal lesions on examination and optical coherence tomography consistent with solar retinopathy. Optical coherence tomography angiography showed a focal area of nonperfusion of the choriocapillaris in the affected eyes. CONCLUSION: Changes to the choriocapillaris layer on optical coherence tomography angiography in two patients with solar retinopathy suggest that damage is not limited to the retina.


Assuntos
Doenças Retinianas , Luz Solar , Angiografia , Humanos , Doenças Retinianas/diagnóstico por imagem , Doenças Retinianas/etiologia , Luz Solar/efeitos adversos , Tomografia de Coerência Óptica
2.
JAMA Ophthalmol ; 137(5): 568-570, 2019 05 01.
Artigo em Inglês | MEDLINE | ID: mdl-30920588

RESUMO

Importance: Ledipasvir-sofosbuvir has become the current standard of care for hepatitis C since its release in 2014. Therefore, potential adverse effects are important to identify. Objective: To report findings of uveitis after treatment with ledipasvir-sofosbuvir for hepatitis C. Design, Setting, and Participants: This case series includes patients treated in an urban academic setting with ledipasvir-sofosbuvir for hepatitis C from June 2015 to June 2017 who are known to have developed signs and symptoms of posterior uveitis. Exposures: All patients had been treated with ledipasvir-sofosbuvir for hepatitis C for a total of 12 weeks. All patients but 1 had finished treatment prior to presentation. Main Outcomes and Measures: Signs of posterior uveitis on ophthalmic testing. Results: Data were collected from 6 patients (median age, 64.5 [range, 54-72] years). Five patients were male; 4 were white, and 2 were African American. The mean (SD) time between beginning of treatment and presentation was 8.8 (5.5) months. Both eyes were affected in 3 of the 6 patients (total, 9 eyes). The median presenting visual acuity in affected eyes was 20/40 (range, 20/20-20/70). All patients had a negative systemic uveitis workup. Five patients presented with blurred vision, and 1 had a paracentral scotoma. The main ocular findings were peripheral vasculitis (in 8 of 9 eyes), papillitis (in 7 of 9 eyes), and cystoid macular edema (in 6 of 9 eyes). The median follow-up was 8 (range, 4-13) months. The median final visual acuity was 20/40 (range, 20/20-20/200). Conclusions and Relevance: In these patients, it appears that treatment with ledipasvir-sofosbuvir for hepatitis C was associated with a mild posterior uveitis different than interferon retinopathy. Given the large number of patients treated with ledipasvir-sofosbuvir, these findings cannot be considered causative, and an association cannot be quantified at this time.


Assuntos
Benzimidazóis/efeitos adversos , Fluorenos/efeitos adversos , Hepatite C Crônica/tratamento farmacológico , Uridina Monofosfato/análogos & derivados , Uveíte Posterior/induzido quimicamente , Idoso , Antivirais/efeitos adversos , Antivirais/uso terapêutico , Benzimidazóis/uso terapêutico , Feminino , Fluorenos/uso terapêutico , Angiofluoresceinografia , Seguimentos , Fundo de Olho , Humanos , Masculino , Pessoa de Meia-Idade , Disco Óptico/patologia , Retina/patologia , Índice de Gravidade de Doença , Sofosbuvir , Fatores de Tempo , Tomografia de Coerência Óptica , Uridina Monofosfato/efeitos adversos , Uridina Monofosfato/uso terapêutico , Uveíte Posterior/diagnóstico , Acuidade Visual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA